abstract |
(57) [Summary]nThe compounds of the present invention relate to compounds of formula I which inhibit factor Xa, pharmaceutical compositions comprising said compounds, the use of said compounds for the treatment of patients suffering from a condition ameliorated by administration of a factor Xa inhibitor. . |